compound 7b (King Saud University)

Compound 7b is an investigational small molecule phenoxyacetic acid derivative developed by researchers at King Saud University and Prince Sattam bin Abdulaziz University. It is being studied as a multifunctional antiepileptic and anti-inflammatory agent. In preclinical studies, Compound 7b demonstrated superior efficacy compared to the reference drug valproic acid, providing complete seizure protection and 100% survival in pentylenetetrazol-induced and pilocarpine-induced seizure models. Its mechanism of action involves the reduction of hippocampal oxidative stress, suppression of neuroinflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6), attenuation of glutamate accumulation, and downregulation of glial activation markers including glial fibrillary acidic protein (GFAP) and ionized calcium-binding adapter molecule 1 (Iba-1). Safety evaluations in animal models have shown no evidence of hepatic, renal, or cardiac toxicity at high doses.

Other names

phenoxyacetic acid derivative 7b